Our data indicate that the Curcumin treatment induces in CML cells, a dose-dependent regulation of AKT phosphorylation, confirmed by the study of gain and loss of function for miR-21. Here, AKT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.